The original instrument and the following digest, which constitutes no part of the
legislative instrument, were prepared by Brandi Cannon.
DIGEST
SB 257 Engrossed 2022 Regular Session Fred Mills
Proposed law requires the La. Medicaid program to provide coverage for a continuous glucose
monitor for the treatment of an enrollee who has any type of diabetes with the use of insulin more
than two times daily or evidence of level 2 or level 3 hypoglycemia or who has glycogen storage
disease type 1a.
Proposed law requires an enrollee who receives coverage for a continuous glucose monitor to attend
regular follow-up visits with a healthcare provider at a minimum of every six months to assess the
ongoing benefit of the enrollee's use of a continuous glucose monitor.
Proposed law requires the La. Dept. of Health to implement the coverage requirement of proposed
law using the most cost-effective solution available to the department.
Effective August 1, 2022.
(Adds R.S. 46:450.8)